Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening: A Qualitative Study
Authors:
- Lily PhamLPLily Pham
- Rebekah J. MolesRMRebekah J. Moles
- Claire L. O’reillyCOClaire L. O’reilly
- Stephen CarterSCStephen Carter
- Camille Raynes-GreenowCamille Raynes-Greenow
- Timothy F. ChenTCTimothy F. Chen
- Corina RaduescuCRCorina Raduescu
- Sue RandallSRSue Randall
- Jacqueline BloomfieldJBJacqueline Bloomfield
- Clara StrowelCSClara Strowel
- Andrea MurphyAMAndrea Murphy
- David GardnerDGDavid Gardner
Open Access
- 5 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (23) , 16295
Abstract
Internationally, 20% of women experience perinatal depression (PND). Healthcare providers including general practitioners and midwives are critical in providing PND screening and support; however, the current workforce is unable to meet growing demands for PND care. As accessible and trusted primary healthcare professionals, pharmacists could provide PND care to complement existing services, thereby contributing to early detection and intervention. This study aimed to explore perinatal women’s views of community pharmacist-delivered PND screening and care, with a focus on their attitudes towards and acceptability of PND screening implementation in community pharmacy. Semi-structured interviews with women (n = 41) were undertaken, whereby interview data were transcribed verbatim and then inductively and thematically analysed. Five overarching themes emerged; “patient experience with existing PND support and screening services”; “familiarity with pharmacists’ roles”; “pharmacist visibility in PND screening care”; “patient—pharmacist relationships” and “factors influencing service accessibility”. Themes and subthemes were mapped to the Consolidated Framework for Implementation Research. Findings highlight participants’ generally positive attitudes towards community pharmacist-delivered PND screening and care, and the potential acceptability of such services provided pharmacists are trained and referral pathways are established. Addressing perceived barriers and facilitators would allow community pharmacist-delivered PND screening and care to support existing PND care models.Keywords
Funding Information
- Lifespan Research Network of the Faculty of Medicine and Health, The University of Sydney
This publication has 52 references indexed in Scilit:
- Barriers and Facilitators to Evidence-based Blood Pressure Control in Community PracticeThe Journal of the American Board of Family Medicine, 2013
- Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR)Implementation Science, 2013
- Community Mental Health Provider Reluctance to Provide Pharmacotherapy May Be a Barrier to Addressing Perinatal Depression: A Preliminary StudyPsychiatric Quarterly, 2012
- What elements of the patient–pharmacist relationship are associated with patient satisfaction?Patient Preference and Adherence, 2012
- Status, challenges and facilitators of consumer involvement in Australian health and medical researchHealth Research Policy and Systems, 2010
- Screening and Counseling for Postpartum Depression By NursesMCN: The American Journal of Maternal/Child Nursing, 2010
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation scienceImplementation Science, 2009
- Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementationInternational Journal of Pharmacy Practice, 2009
- A geographic comparison of the prevalence and risk factors for postnatal depression in an Australian populationAustralian and New Zealand Journal of Public Health, 2008
- Consumer involvement in health research: fact or fiction?British Journal of Clinical Governance, 2002